Greenwich Stock Story

Greenwich investor sentiment overview provides quick insight into current market opportunities from investing in Greenwich Lifesciences. The current market sentiment together Greenwich Lifesciences' historical and current headlines can help investors to time the market. Many technical investors use Greenwich Lifesciences stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Check out Risk vs Return Analysis.
  
Refresh
Greenwich Lifesciences stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Greenwich daily returns and investor perception about the current pice of Greenwich Lifesciences as well as its diversification or hedging effects on your existing portfolios.
Fluidigm Completes 250 Million Strategic Capital Infusion and Changes Name to Standard BioTools Inc. - GlobeNewswire
Fluidigm Completes 250 Million Strategic Capital Infusion and Changes Name to Standard BioTools Inc. GlobeNewswire

news
  
Fluidigm Completes 250 Million Strategic Capital Infusion and Changes Name to Standard BioTools Inc. GlobeNewswire
Follow Benchmarks with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker

Greenwich Lifesciences Fundamental Analysis

We analyze Greenwich Lifesciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Greenwich Lifesciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Greenwich Lifesciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Valuation

Current Valuation Comparative Analysis

Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Peers

Your Trending Equities

FRHC  2.91   
0%
87.0%
VLUE  1.15   
0%
34.0%
VST  0.18   
0%
5.0%
QYLD  0.17   
0%
5.0%
POW  0.10   
0%
3.0%
TAXI  0.00   
0%
0%
HAR  0.00   
0%
0%
SSS  0.00   
0%
0%
HZNSF  0.00   
0%
0%
GDI  0.00   
0%
0%
DPS  0.00   
0%
0%
AMN  0.11   
3.0%
0%
BNPQF  0.15   
4.0%
0%
FMURX  0.32   
9.0%
0%
MOTO  0.35   
10.0%
0%
TWST  0.97   
29.0%
0%
VGLT  1.52   
45.0%
0%
ARMK  1.58   
47.0%
0%
XOM  1.80   
54.0%
0%
MHNC  3.34   
100.0%
0%
Please check Risk vs Return Analysis. Note that the Greenwich Lifesciences information on this page should be used as a complementary analysis to other Greenwich Lifesciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Tools for Greenwich Stock

When running Greenwich Lifesciences price analysis, check to measure Greenwich Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Greenwich Lifesciences is operating at the current time. Most of Greenwich Lifesciences' value examination focuses on studying past and present price action to predict the probability of Greenwich Lifesciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Greenwich Lifesciences' price. Additionally, you may evaluate how the addition of Greenwich Lifesciences to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go